UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy Journal article
Meng, Jialin, Jiang, Aimin, Lu, Xiaofan, Gu, Di, Ge, Qintao, Bai, Suwen, Zhou, Yundong, Zhou, Jun, Hao, Zongyao, Yan, Fangrong, Wang, Linhui, Wang, Haitao, Du, Juan, Liang, Chaozhao. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy[J]. iMeta, 2023, 2(4), e147.
Authors:  Meng, Jialin;  Jiang, Aimin;  Lu, Xiaofan;  Gu, Di;  Ge, Qintao; et al.
Favorite | TC[WOS]:10 TC[Scopus]:13  IF:23.7/23.7 | Submit date:2024/01/10
Clear Cell Renal Cell Carcinoma  Immune Activation  Molecular Subtyping  Multiomics  
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies Journal article
Jialin Meng, Jingjing Gao, Xiao Li, Rui Gao, Xiaofan Lu, Jun Zhou, Fangrong Yan, Haitao Wang, Yi Liu, Zongyao Hao, Xiansheng Zhang, Chaozhao Liang. TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies[J]. Cellular Oncology, 2023, 46(3), 745-759.
Authors:  Jialin Meng;  Jingjing Gao;  Xiao Li;  Rui Gao;  Xiaofan Lu; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.9/5.2 | Submit date:2023/07/27
Fscn1  Immune-exhausted  Molecular Subtype  Testicular Germ Cell Tumor